News

Experts clash over Germany’s plan to restrict online medical cannabis access, as policymakers, doctors, industry, and patients debate impacts on imports, prescriptions, and patient access. The post Experts divided on German plan to tighten medical cannabis access appeared first on StratCann.

A flurry of cannabis business transactions came on the heels of President Donald Trump’s Dec. 18 executive order – with many more to come once marijuana rescheduling is finalized. Flurry of cannabis M&A that followed Trump marijuana rescheduling a sign of things to come is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

A flurry of cannabis business transactions came on the heels of President Donald Trump’s Dec. 18 executive order – with many more to come once marijuana rescheduling is finalized. Flurry of cannabis M&A that followed Trump marijuana rescheduling a sign of things to come is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Michigan cannabis sales for December rose from a year ago as they increased sequentially by 3.8%, which was +0.5% on a per-day basis. At $269.7 million, sales were up 1.6% from a year earlier: The Michigan Cannabis Regulatory Agency breaks out sales by medical and adult-use, with medical sales falling 50.2% from a year ago to $0.4 [ . . . ]

Recreational cannabis sales increased by $17.6 million, but medical sales dropped $21 million from the previous year. Connecticut cannabis retailers sell record number of items amid price drop is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Recreational cannabis sales increased by $17.6 million, but medical sales dropped $21 million from the previous year. Connecticut cannabis retailers sell record number of items amid price drop is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

New Hampshire lawmakers on Wednesday took up a pair of bipartisan bills to legalize the regulated use of psilocybin for medical purposes. At a hearing before the House Health, Human Services and Elderly Affairs Committee, members heard public testimony on the proposals: HB 1809 from Rep. Buzz Scherr (D) and HB 1796 from Rep. Michael Moffett (R). Both measures seek to create a regulatory pathway for patients with certain conditions to access the psychedelic for therapeutic use through a program overseen by the state Department of Health and Human Services (DHHS). But Moffett’s legislation is . . .

New Jersey’s Senate president has filed a bill that would allow marijuana companies to engage in interstate commerce. Under the proposal from Sen. Nicholas Scutari (D), the governor would be empowered to “enter into an agreement with another state or states authorizing medicinal or personal-use commercial cannabis activity, or both, between entities licensed under the laws of the contracting state and entities operating with a State license” in New Jersey. However, the reform would only take effect under certain conditions, such as if federal law changed to explicitly allow interstate . . .

By Jonathan Ballard, Vice President of LeafyPack Jonathan Ballard is Vice President of LeafyPack, bringing deep cannabis and agricultural expertise to advance automation-driven partnerships, sustainable packaging programs, and creative financing solutions supporting a resilient cannabis supply chain. Table of Contents Manufacturing at a breaking point Labor isn’t the only cost Stop thinking about machines, start thinking about systems Lessons from other industries Future-proofing doesn’t mean guessing The cost of waiting Looking ahead Manufacturing at a breaking point If you’re still relying . . .

Aurora Cannabis advances PM2 powdery mildew resistance research, integrating disease-resistant genetics into elite cultivars, aiming to commercialize resilient cannabis strains that improve plant health, quality,… The post Aurora Cannabis shares progress in disease resistance research appeared first on StratCann.

For some cannabis consumers, unexpected symptoms make it difficult to get the full benefits of these products. Developing concerns such as nasal congestion, skin irritation, headaches, coughing, or gastrointestinal discomfort could raise an important question: Could allergies be affecting my cannabis experience? Understanding how allergies and sensitivities affect cannabis consumers and when testing and treatment [ . . . ] Source: Do Allergies Affect My Cannabis Experience? from Heady NJ

Strategic partnerships introduce insurance as a new service category and complementary revenue stream within the Safe Harbor Advantage Partner Network DENVER, Jan. 14, 2025 – SHF Holdings, Inc., d/b/a Safe Harbor (the “Company”) (NASDAQ: SHFS), a fintech leader in providing banking, lending and financial services to the regulated cannabis and hemp industries, announced the expansion of its client offerings to include cannabis-specific insurance solutions through strategic partnerships with Frontier Risk and AlphaRoot. The new insurance capabilities are delivered through the Safe Harbor . . .

Hawaii state Rep. David Tarna (D) is planning to introduce a bill later this month to put a cannabis legalization constitutional amendment on the ballot for voters to decide, Honolulu Star Advertiser reports. “My intention behind this is to protect public safety, to protect consumer safety and to support public education campaigns so that adults will use cannabis responsibly.” – Tarnas, in the report The proposal will require at least a two-thirds majority to pass the Legislature, and the legalization issue is unpopular with many elected officials. Additionally, if the question does . . .

Three adult-use cannabis licensees in Connecticut operating under the Crisp Cannabis brand, the company looking to acquire the three businesses, Mohave CT LLC, and the principals of each entity have agreed to a $416,000 settlement with state officials over alleged antitrust and other violations. The allegations against Mohave and the three Crisp Cannabis licensees, located in Bridgeport, East Hartford, and Cromwell, claimed that the businesses prematurely transferred operational control and beneficial ownership to the would-be purchaser more than 100 days before informing officials of the . . .

Ohio’s attorney general has rejected activists’ referendum petition to block parts of a restrictive marijuana and hemp law from going into effect, saying its summary is “misleading” and must be revised in order to proceed. “Upon review of the summary, we identified omissions and misstatements that, as a whole, would mislead a potential signer as to the scope and effect of S.B. 56,” Attorney General Dave Yost (R) wrote in a letter to the petitioners on Tuesday. The referendum, led by Ohioans for Cannabis Choice, seeks to repeal key components of a bill the governor recently signed to scale . . .

CHARLOTTE, N.C., Jan. 14, 2026 /PRNewswire/ – cbdMD, Inc(NYSE American: YCBD), a leading innovator in hemp-derived wellness products, announced today the closing of the acquisition of substantially all of the assets of Bluebird Botanicals, one of the longest-standing brands in the CBD industry, providing an established and complementary revenue base to strengthen cbdMD’s long-term growth strategy. The transaction was completed through an asset purchase comprised of an initial share issuance and earnout shares. For more details, including specific terms and conditions, please see the Form 8-K . . .

Register here Webinar overview This webinar will feature Harris Sliwoski attorneys Jason Adelstone (Denver, CO) and Vince Sliwoski (Portland, OR). Jason and Vince will examine a pair of significant developments for federal cannabis law and policy in 2026. These developments are: 1) last month’s Executive Order from President Trump, to reschedule marijuana from Schedule I to Schedule III of the Controlled Substances Act, and 2) recent Congressional legislation to redefine “hemp”, effective this November. Please join us this Thursday, January 15, 2026 at 10 a.m. PST / 1 p.m. EST! Feel free to . . .

It’s been eight years since Canada legalized marijuana nationwide, and a new poll shows that support for the reform is increasing over time. Relatively few Canadians want to legalize other drugs, however. Roughly two-thirds of Canadian adults (65 percent) now say they agree with cannabis being legal, according to the survey from Research Co. That’s up three percentage points since the firm last polled on the topic in 2024. Just 29 percent of respondents disagree with marijuana legalization, and 6 percent say they’re not sure how they feel about the reform. The survey, which was conducted from . . .

Joe Rogan seemed stunned to hear Sen. Rand Paul (R-KY) tell him on a new episode of his podcast that certain marijuana businesses joined hands with the alcohol industry to lobby in favor of a federal ban on most hemp THC products. During a wide-ranging interview on the Joe Rogan Experience that aired on Tuesday, the senator discussed his months-long effort to fight against the recriminalization of hemp under a spending bill signed into law by President Donald Trump in November. Paul again faulted his home-stare colleague Sen. Mitch McConnell (R-KY) for spearheading the ban, which hemp . . .

The SQDC has issued a recall for one lot of a 3.5 gram cannabis flower SKU from Lunaire due to “a contaminant level exceeding Health… The post SQDC issues recall for one lot of Lunaire’s Nouvelle Lune appeared first on StratCann.

Publicly traded marijuana extraction specialist Medipharm Labs Corp (TSE: LABS) (OTCMKTS: MEDIF) (FRA: MLZ) has officially entered Latin America through a Costa Rican supply agreement. The Ontario-headquartered company announced on Jan. 13 that it would begin shipping its medicinal cannabis products to a subsidiary of Remidose Aerosols in the region. Merchandise MediPharm will provide include oils, flower, metered dose inhalers and tinctures. The news follows Costa Rica officially starting regulated medical cannabinoid sales in June after years of advocacy efforts and procedural hurdles. . . .

Santa Monica’s city council planned to discuss proposed updates to its social equity licensing framework. Set to begin accepting applications this month, the proposed changes would give preferred treatment to individuals who meet two out of three qualifications — cannabis arrest history, residence in designated zip codes and low household income — instead of all three. Many other states and municipalities have attempted similar social equity programs, often with dismaying results. Next door the city of Los Angeles . . . Log in or become a WeedWeek Member to read this article. The post . . .

The NJ Cannabis Regulatory Commission (NJ-CRC) denied the annual license renewal application of Mad Hatter Dispensary LLC. The dispensary, which is in Avenel in Woodbridge in Middlesex County, was considered separately from other non-controversial license renewals. Acting Executive Director Christopher Riggs noted that NJ cannabis licenses have to be renewed annually, hence the name. ” . . . It [ . . . ] Source: NJ-CRC Denies Mad Hatter Dispensary License Renewal from Heady NJ

Cannabis policy modernization efforts are spreading across Europe at an increasing rate, with Germany continuing to serve as the continental cannabis policy and industry leader. As Germany’s legal industry and other European markets continue to expand, the International Cannabis Business Conference (ICBC) remains at the heart of it all. ICBC is once again bringing Europe’s largest and longest-running cannabis B2B event to Berlin on April 13th-15th, 2026. ICBC Berlin 2026 will be held at Germany’s largest conference and entertainment center, the iconic Estrel Berlin Hotel. The schedule for . . .

Elections fraud allegations lodged against the campaign to end Massachusetts’ $1.65 billion adult-use cannabis market may be difficult to prove. Even if the claims that signature-gatherers for a Coalition for a Healthy Massachusetts deliberately misled voters are sustained, they may not be enough stop cannabis sales recriminalization from going on the ballot, according to the [ . . . ] Despite fraud allegations, campaign to end $1.6 billion Massachusetts marijuana industry likely to proceed is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs